Zusammenfassung
Das Auftreten einer Peritonealkarzinose ist allgemein mit einer schlechten Prognose verknüpft. Obwohl einige Patienten auch relativ lange asymptomatisch bleiben können, manifestiert sich die Peritonealkarzinose im Verlauf mit typischen Symptomen: abdominelle Schmerzen, abdominelle Distension, Aszites, Gewichtsverlust, abdominale Resistenzen, Übelkeit, intestinale Obstruktion, u. a.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Albanese AM, et al. (2009) Peritoneal surface area: measurements of 40 structures covered covered by peritoneum. Surg Radiol Anat 31: 369–377
Arrington A, Kim J (2014) Diseases of the peritoneum Retroperitoneum. ACS Surgery …
Bleibel W, Espat NJ (2016) Peritoneal cancer. Medscape
Chua TC, et al. (2011) 23 Determining the Association Between Preoperative Computed tomogrpha findings and postoperative outcomes Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Annals of surgical oncology
Coccolini F, et al. (2013) Peritoneal carcinomatosis. World journal of gastroenterology
David CZ, et al. (1989) Peritoneal Carcinomatosis in Nongynecolagic Malignancy; A Prospective Study of Prognostic Factors. Cancer 63: 364–367
Dunton CJ (2002) Management of Treatment-Related Toxicity in advanced ovarian cancer. The Oncologist
Esquivel J, Sugarbaker P (2000) Clinical presentation of the pseudomyxoma peritonei syndrome. British journal of science
Fallis SA, Moran BJ (2015) Management of pseudomyxoma peritonei. JBUON
Hamazoe R, Maeta M, Kaibara N (1994) Intraperitoneal themochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer
Jayne DG, Fook S, Loi C, Seow-Choen F (2002) Peritoneal carcinomatosis from colorectal cancer. British journal of surgery
Klaver YL, et al. (2012) Peritoneal carcinomatosis of colorectal origin: Incidence,prognosis and treatment options. World Journal of Gastroenterology
Kobayashi D, Kodera Y, Pelz, et al. (2010) Evaluation of Best Supportive Care and Systemic Chemotherapy as Treatment Stratified according to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for Peritoneal Carcinomatosis of Colorectal Origin. BMC Cancer 10: 689
Kobayashi D, Kodera Y (2017) Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. The International Gastric Cancer Association and The Japanese Gastric Cancer Association
Kusamura S, et al. (2010) Pathophysiology and biology of peritoneal carcinomatosis. World journal of gastrointestinal oncology
Lemoine L, et al. (2016). Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum. World journal of gastroenterology
Levy AD, et al. (2008) Primary Peritoneal Tumors: Imaging. Radiographics
McLaughlin PD, et al. (2012) Neoplastic Diseases of theperitoneum and Mesentery. American Journal of Roentgenology
Meyers MA (1973) Distribution of intraabdominal malignant seeding: Dependency on dynamics of flow of scitich fluid. American Journal of Roentgenology
Moran BJ, Cecil TD (2003) The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surgical Oncology clinics
Nadiradze G, et al. (2016) Journal of gastrointestinal surgery
Orgiano L, et al. (2016) The role of «closed abdome» hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience. Support care cancer
Pelz JO, et al. (2010) Evaluation of Best Supportive Care and Systemic Chemotherapy as Treatment Stratified according to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for Peritoneal Carcinomatosis of Colorectal Origin. BMC Cancer 10: 689
Rodt AP, et al. (2013) Clinical course for patients with peritoneal. World Journal of Surgical Oncology
Royal RE (2007) Diagnosis and Management of Peritoneal Carcinomatosis Arising From Adenocarcinoma of the Colon and Rectum. Seminars in Oncology
Sadeghi B, et al. (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88: 358–363
Sano T (2001) Is peritoneal carcinomatosis an incurable disease or a controllable locorigional condition? Challenge of surgeons with hyperthermic intraperitoneal chemotherapy. Japanese journal of cliniical oncology
Segelman J, et al. (2012) Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. British journal of Surgery
Sugarbaker PH (ed) (1996) Peritoneal carcinomatosis: Principle of management. Kluwer Academic Publishers
Tempfer CB, et al. (2015) Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study. Anticancer Research
Thomassen I, et al. (2013) Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin. Dis Colon Rectum 56: 1373–1380
van der Wal J, Jeekel J (2007) Biology of the peritoneum in normal homeostasis and after surgical trauma. Colorectal disease
Verwaal VJ, et al. (2003) Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer. J Clin Oncol 21: 3737–3743
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Tepel, J., Ajah, D. (2018). Natürlicher Verlauf der Peritonealkarzinose. In: Rau, B., Piso, P., Königsrainer, A. (eds) Peritoneale Tumoren und Metastasen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54500-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-54500-3_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-54499-0
Online ISBN: 978-3-662-54500-3
eBook Packages: Medicine (German Language)